FOXO4-DRI Vial

FOXO4-DRI is a senolytic peptide designed to target senescent cells that have stopped dividing but remain metabolically active.

By disrupting the interaction between FOXO4 and p53 proteins, it supports the selective removal of dysfunctional cells and promotes a healthier environment for tissue renewal.

Synonyms:
FOXO4 D-Retro-Inverso
Molecular Formula:
C₁₁₂H₁₇₈N₃₆O₃₂
Form:
Vial
Raw material
Raw material
USA
Country of origin
Country of origin
UAE
Purity
Purity
99%
stamp

Understanding Cellular Senescence

Most cells divide, perform their function, and are eventually removed when they become damaged. Senescent cells behave differently: they stop dividing but resist normal programmed cell death and may remain inside tissues for extended periods.

These cells can release inflammatory signals, enzymes, and other molecules that affect neighboring tissue. Their gradual accumulation is associated with reduced regenerative capacity, chronic low-grade inflammation, and age-related changes in organ function.

How FOXO4-DRI Targets Senescent Cells

FOXO4 is a transcription factor that helps senescent cells remain resistant to apoptosis. It binds to the p53 protein and keeps it inside the cell nucleus, preventing p53 from activating the normal self-destruction pathway.

FOXO4-DRI is designed to enter these cells and interrupt the FOXO4-p53 interaction. Once released, p53 can move out of the nucleus and initiate apoptosis, allowing the body to remove the dysfunctional cell through its natural clearance mechanisms.

A Selective Senolytic Mechanism

The purpose of a senolytic compound is not to stimulate every cell or accelerate cell division. Its role is to help distinguish between functioning cells and senescent cells that no longer contribute normally to tissue health.

FOXO4-DRI focuses on a survival mechanism that is particularly important to senescent cells. This targeted action supports the removal of cellular debris while allowing healthier cells to continue their normal activity.

Reducing the Senescence-Associated Environment

Senescent cells can produce a collection of inflammatory molecules known as the senescence-associated secretory phenotype, or SASP. These signals may influence immune activity, tissue structure, and the behavior of nearby cells.

Reducing the senescent-cell burden may help create a more balanced tissue environment. Lower exposure to SASP signaling can support normal cellular communication, regenerative processes, and a more controlled inflammatory response.

Tissue Renewal and Regenerative Capacity

Tissue recovery depends not only on creating new cells but also on removing cells that no longer function correctly. When senescent cells occupy space and release disruptive signals, normal regeneration may become less efficient.

FOXO4-DRI supports cellular turnover by helping clear dysfunctional cells from the tissue environment. This may allow healthier cells, stem-cell populations, and repair mechanisms to operate under more favorable conditions.

Energy, Resilience, and Age-Related Changes

The accumulation of senescent cells can affect tissues with high metabolic demands, including muscles, the cardiovascular system, and organs responsible for detoxification and energy regulation.

By supporting senescent-cell clearance, FOXO4-DRI may contribute to improved cellular resilience and more efficient tissue function. Its mechanism is centered on cellular quality control rather than temporary stimulation.

FOXO4-DRI in Longevity Programs

Longevity strategies often focus on mitochondrial function, DNA maintenance, metabolic balance, and protection from oxidative stress. FOXO4-DRI approaches the same goal from a different angle by targeting cells that have already entered a dysfunctional senescent state.

This makes the peptide relevant to advanced programs focused on cellular renewal and age-related tissue changes. Its senolytic mechanism can complement approaches that support energy production, recovery, and regenerative signaling.

    Biohack

    Biohack your life with us

    Personalized expert consultation